Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone IM and Oral in Schizophrenia with Acute Agitation
NCT00136994Phase 3Completed
- Sponsor
- Viatris
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziprasidone in schizophrenia, sponsored by Viatris. Started Mar 2003; status: completed.
02
Drugs
ziprasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00136994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136994.